On the Discovery, Biological Effects, and Use of Cisplatin and Metallocenes in Anticancer Chemotherapy

被引:122
作者
Gomez-Ruiz, Santiago [2 ]
Maksimovic-Ivanic, Danijela [3 ]
Mijatovic, Sanja [3 ]
Kaluderovic, Goran N. [1 ]
机构
[1] Univ Halle Wittenberg, Inst Chem, D-06120 Halle, Germany
[2] Univ Rey Juan Carlos, ESCET, Dept Quim Inorgan & Analit, Mostoles 28933, Spain
[3] Univ Belgrade, Inst Biol Res Sinisa Stankov, Belgrade 11060, Serbia
关键词
ESTROGEN-RECEPTOR MODULATORS; NUCLEOTIDE EXCISION-REPAIR; X-LINKED INHIBITOR; TI-IV UPTAKE; TITANOCENE DICHLORIDE; OVARIAN-CANCER; DNA-ADDUCTS; PHASE-I; MOLYBDOCENE DICHLORIDE; CELL-DEATH;
D O I
10.1155/2012/140284
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The purpose of this paper is to summarize mode of action of cisplatin on the tumor cells, a brief outlook on the metallocene compounds as antitumor drugs as well as the future tendencies for the use of the latter in anticancer chemotherapy. Molecular mechanisms of cisplatin interaction with DNA, DNA repair mechanisms, and cellular proteins are discussed. Molecular background of the sensitivity and resistance to cisplatin, as well as its influence on the efficacy of the antitumor immune response was evaluated. Furthermore, herein are summarized some metallocenes (titanocene, vanadocene, molybdocene, ferrocene, and zirconocene) with high antitumor activity.
引用
收藏
页数:14
相关论文
共 148 条
  • [21] 2-D
  • [22] Dabrowiak J., 2009, METALS MED
  • [23] Daino H, 2000, BLOOD, V95, P2577
  • [24] RETRACTED: Akt phosphorylation and stabilization of X-linked inhibitor of apoptosis protein (XIAP) (Retracted Article)
    Dan, HC
    Sun, M
    Kaneko, S
    Feldman, RI
    Nicosia, SV
    Wang, HG
    Tsang, BK
    Cheng, JQ
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (07) : 5405 - 5412
  • [25] Cellular survival: a play in three Akts
    Datta, SR
    Brunet, A
    Greenberg, ME
    [J]. GENES & DEVELOPMENT, 1999, 13 (22) : 2905 - 2927
  • [26] Signal transduction by the JNK group of MAP kinases
    Davis, RJ
    [J]. CELL, 2000, 103 (02) : 239 - 252
  • [27] Platinum-based chemotherapy in metastatic breast cancer: current status
    Decatris, MP
    Sundar, S
    O'Byrne, KJ
    [J]. CANCER TREATMENT REVIEWS, 2004, 30 (01) : 53 - 81
  • [28] DECONTI RC, 1973, CANCER RES, V33, P1310
  • [29] Cisplatin Restores TRAIL Apoptotic Pathway in Glioblastoma-Derived Stem Cells through Up-regulation of DR5 and Down-regulation of c-FLIP
    Ding, Lijuan
    Yuan, Changji
    Wei, Feng
    Wang, Guangyi
    Zhang, Jing
    Bellail, Anita C.
    Zhang, Zhaobin
    Olson, Jeffrey J.
    Hao, Chunhai
    [J]. CANCER INVESTIGATION, 2011, 29 (08) : 511 - 520
  • [30] CHARACTERIZATION OF THE ADDUCTS PRODUCED IN DNA BY CIS-DIAMMINEDICHLOROPLATINUM(II) AND CIS-DICHLORO(ETHYLENEDIAMINE)PLATINUM(II)
    EASTMAN, A
    [J]. BIOCHEMISTRY, 1983, 22 (16) : 3927 - 3933